Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-28

Clinical Trial Update: The Effect of the Nutraceutical "Hemofix" on the Coagulation System [NA]

View source ↗

Summary

This clinical trial update reports the withdrawal of a study evaluating the nutraceutical Hemofix on coagulation in von Willebrand disease and menorrhagia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemofix

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Von Willebrand Disease, Menorrhagia | NA | Status: WITHDRAWN